PTK2 and prostate carcinoma: Phosphorylated FAK (pFAK) and VEGF expression was investigated in a triple negative breast cancer cell line (MDA-MB-231), adenocarcinoma alveolar cancer cell line (A549), and a prostate cancer cell line (DU145).